VTM effectively alleviated ALI by reducing of the wet-to-dry weight (W/D) ratio, serum inflammatory cytokines PGE2 and LTB4 levels, and lung tissues IL-1β, IFN-γ, TNF-α and MCP-1 levels. This evidence concerns the gene IL1B and acute respiratory distress syndrome.